Application of juglone to preparation of medicament for treating autoimmune and inflammatory diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
An autoimmune and juglone technology, applied in allergic diseases, blood diseases, sensory diseases, etc., can solve problems such as antigen signal stimulation
Inactive Publication Date: 2012-11-28
TIANJIN MEDICAL UNIV
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] At present, the pathological mechanism of EAE/MS is not fully understood, but it is generally believed that EAE is an inflammatory disease of the central nervous system caused by au
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] 1.1 Construction method of EAE mouse model
[0022] (1) Experimental animals and sources
[0023] Thirty female wild-type C57BL / 6 pathogen-free (SPF grade) mice, 6-8 weeks old, weighing 18-20g, were purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. and bred in the Experimental Animal Center of Tianjin Medical University , The mouse feeding environment is room temperature 20-25 ℃, relative humidity 40%-60%.
[0024] (2) Preparation of Antigen Adjuvant Emulsion
[0025] 100 μg of MOG35-55 polypeptide and 500 μg of inactivated Mycobacterium tuberculosis (Mycobacterium tuberculosis, purchased from Difco) were completely mixed with 100 μl of normal saline and 100 μl of Freund’s adjuvant (purchased from SIGMA), and emulsified.
[0026] (3) Experimental grouping
[0027] In order to study the drug effect of juglone in the mouse EAE animal model, the mice were randomly divided into four groups, with 8 mice in each group, two normal saline control ...
Embodiment 2
[0098] Mix 50g of juglone and 280g of starch evenly, make granules with starch slurry (take 220g of starch and make starch slurry with water), sieve, dry, and pack into capsules.
Embodiment 3
[0100] Mix 80g of juglone and 340g of starch evenly, make granules with starch slurry (take 210g of starch to make starch slurry with water), sieve, dry, add 6‰ magnesium stearate, mix well, press into tablets, and coat with film. .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an application of juglone to preparation of a medicament for treating autoimmune and inflammatory diseases. As proved by an experimental result, the juglone can be used for lowering the disease incidence, average clinical score, highest clinical score and total clinical scores of mouse experimental autoimmune encephalomyelitis, lowering the percentages of an IFN (Interferon)-gamma secretion-relevant cell Th1 and a 1L-17A secretion-relevant cell Th17 in spinal marrow of mouse experimental autoimmune encephalomyelitis in a CD4+T cell, inhibiting the proliferation of a cell T induced by MOG (Myelin Oligodendrocyte Glycoprotein) of the mouse experimental autoimmune encephalomyelitis, and lowering the expression of CD11b+ angtigen presentation cells CD83 and MHCII in the spleen of the mouse experimental autoimmune encephalomyelitis. The juglone for preparing a medicament for inhibiting an immune system related to the invention is expected to become a medicament for clinically treating autoimmune inflammatory diseases such as multiple sclerosis, acute disseminated encephalomyelitis and the like.
Description
technical field [0001] The invention belongs to the technical field of application of traditional Chinese medicines, and relates to the application of juglone, a monomer of traditional Chinese medicine, in the preparation of medicines for treating autoimmune diseases and nervous system inflammatory diseases. Background technique [0002] Walnut catalpa (Juglans mandshurica Maxim.) is a deciduous tree of Juglans family Juglans, which is a precious timber tree species and an important medicinal plant. Juglone (Juglone; Nucin) is also known as 5-hydroxy-1,4-naphthoquinone; 5-hydroxy-1,4-naphthalenedione. It is a hydroxynaphthoquinone compound isolated from the fresh root bark, branch bark and green peel of Juglans, and it is the main active substance in Juglans. Walnut peeling is an astringent medicine, which has certain curative effects on bacillary dysentery and bone tuberculosis. In recent years, a large number of studies have shown that juglone has biological activities s...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more